Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.

Acta cardiologica

Volumn 64, Issue 5, 2009, Pages 589-595

  Fujimura, Mitsunori ^a   Akaike, Masashi ^a   Iwase, Takashi ^a   Yoshida, Sumiko ^a   Sumitomo, Yuka ^a   Yagi, Shusuke ^a   Ikeda, Yasumasa ^a   Hashizume, Shunji ^a   Aihara, Ken ichi ^a   Nishiuchi, Takeshi ^a   Yasumura, Yoshio ^a   Matsumoto, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CARBAZOLE DERIVATIVE; CARVEDILOL; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FOLLOW UP; HEART STROKE VOLUME; HUMAN; IMMUNORADIOMETRIC ASSAY; JAPAN; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTOLIC HEART FAILURE; TIME; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BIOLOGICAL MARKERS; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; IMMUNORADIOMETRIC ASSAY; JAPAN; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROPANOLAMINES; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 75749083369     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.64.5.2042687     Document Type: Article

References (0)